Tilray Brands (NASDAQ: TLRY) has become known as a cannabis company.
The company expanded its product offerings to include beverages such as beer, although Tilray’s cannabis and wellness (hemp-based food) divisions combined for 38% of fiscal 2025 revenue (ended May 31)
Given how crucial cannabis is to the company’s results, investors considering investing in Tilray Brands’ stock should understand the importance of markets outside the United States. Focus outside the U.S. The cannabis division accounts for a significant share of Tilray Brands’ sales and the largest portion of its profitability.
The segment generated $196.9 million in sales for the first nine months of the year, or 31% of the total. But it produced a gross profit of $75.4 million, the company’s largest profit source, representing 44%. These sales come from outside the United States, including Canada and the European Union, where regulations on medicinal and recreational marijuana aren’t as stringent.